SP
SIH Partners Portfolio holdings
AUM
$1.05B
1-Year Return
21.73%
This Quarter Return
+0.72%
1 Year Return
+21.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.05B
AUM Growth
-$86.2M
(-7.6%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-10.76%
Top 10 Holdings %
Top 10 Hldgs %
64.62%
Holding
292
New
48
Increased
34
Reduced
31
Closed
159
Top Buys
| 1 |
Alibaba
BABA
|
$122M |
| 2 |
JD.com
JD
|
$60.2M |
| 3 |
AMRZ
Amrize Ltd
AMRZ
|
$49.7M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$46M |
| 5 |
Li Auto
LI
|
$25.7M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$136M |
| 2 |
UBS Group
UBS
|
$125M |
| 3 |
Stellantis
STLA
|
$56.7M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$28.1M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
$25.8M |
Sector Composition
| 1 | Consumer Discretionary | 52.11% |
| 2 | Materials | 9.59% |
| 3 | Communication Services | 8.3% |
| 4 | Technology | 4.16% |
| 5 | Healthcare | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cytokinetics
CYTK
$5.95B
| – | – |
-7,307
| Closed | -$294K |
|
227
Danaher
DHR
$143B
| – | – |
-5,930
| Closed | -$1.22M |
|
228
DraftKings
DKNG
$23.5B
| – | – |
-75,192
| Closed | -$2.5M |
|
229
Denison Mines
DNN
$2.04B
| – | – |
-35,873
| Closed | -$46.6K |
|
230
DexCom
DXCM
$31.7B
| – | – |
-3,726
| Closed | -$254K |
|
231
Elevance Health
ELV
$69.4B
| – | – |
-2,294
| Closed | -$998K |
|
|
232
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| – | – |
-310,311
| Closed | -$28.1M |
|
233
Erasca
ERAS
$420M
| – | – |
-17,067
| Closed | -$23.4K |
|
234
Esperion Therapeutics
ESPR
$510M
| – | – |
-11,411
| Closed | -$16.4K |
|
235
Edwards Lifesciences
EW
$47.5B
| – | – |
-5,158
| Closed | -$374K |
|
236
iShares MSCI South Korea ETF
EWY
$5.18B
| – | – |
-15,615
| Closed | -$844K |
|
237
Exelixis
EXEL
$10.1B
| – | – |
-17,489
| Closed | -$646K |
|
238
Extra Space Storage
EXR
$30.5B
| – | – |
0
| – | – |
|
239
Foot Locker
FL
$2.3B
| – | – |
-24,319
| Closed | -$343K |
|
240
Franco-Nevada
FNV
$36.6B
| – | – |
-1,483
| Closed | -$234K |
|
241
Amicus Therapeutics
FOLD
$2.47B
| – | – |
-19,364
| Closed | -$158K |
|
242
GE HealthCare
GEHC
$33.8B
| – | – |
-4,277
| Closed | -$345K |
|
243
Geron
GERN
$880M
| – | – |
-39,868
| Closed | -$63.4K |
|
244
Guardant Health
GH
$7.65B
| – | – |
-10,397
| Closed | -$443K |
|
245
Gilead Sciences
GILD
$140B
| – | – |
-112,052
| Closed | -$12.6M |
|
246
GameStop
GME
$10B
| – | – |
-311,420
| Closed | -$6.95M |
|
247
Immunovant
IMVT
$2.81B
| – | – |
-10,705
| Closed | -$183K |
|
248
Incyte
INCY
$16.7B
| – | – |
-14,135
| Closed | -$856K |
|
249
Insmed
INSM
$30.1B
| – | – |
-11,415
| Closed | -$871K |
|
250
Ionis Pharmaceuticals
IONS
$9.46B
| – | – |
-11,999
| Closed | -$362K |
|